Association Between Statin Use and the Incidence of Atrial Fibrillation Following Hospitalization for Coronary Artery Disease

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1655-1660

  Kulik, Alexander ^a   Singh, Jagmeet P ^b   Levin, Raisa ^c   Avorn, Jerry ^c   Choudhry, Niteesh K ^c  

^a Boca Raton Community Hospital   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIGENIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GOVERNMENT; HEALTH BEHAVIOR; HEALTH PROGRAM; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; DRUG PRESCRIPTIONS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MYOCARDIAL REVASCULARIZATION; PATIENT DISCHARGE; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77953120103     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.341     Document Type: Article

References (27)

1. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
2. Kumagai K., Nakashima H., and Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62 (2004) 105-111
3. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
4. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
5. Pliquett R.U., Cornish K.G., Peuler J.D., and Zucker I.H. Simvastatin normalizes autonomic neural control in experimental heart failure. Circulation 107 (2003) 2493-2498
6. Lefer A.M., Scalia R., and Lefer D.J. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res 49 (2001) 281-287
7. Pound E.M., Kang J.X., and Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res 42 (2001) 346-351
8. Siu C.W., Lau C.P., and Tse H.F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 92 (2003) 1343-1345
9. Patti G., Chello M., Candura D., Pasceri V., D'Ambrosio A., Covino E., and Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 114 (2006) 1455-1461
10. Mariscalco G., Lorusso R., Klersy C., Ferrarese S., Tozzi M., Vanoli D., Domenico B.V., and Sala A. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 84 (2007) 1158-1164
11. Lertsburapa K., White C.M., Kluger J., Faheem O., Hammond J., and Coleman C.I. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 135 (2008) 405-411
12. Young-Xu Y., Jabbour S., Goldberg R., Blatt C.M., Graboys T., Bilchik B., and Ravid S. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92 (2003) 1379-1383
13. Pellegrini C.N., Vittinghoff E., Lin F., Hulley S.B., and Marcus G.M. Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS Trial. Heart 95 (2009) 704-708
14. Kulik A., Levin R., Ruel M., Mesana T.G., Solomon D.H., and Choudhry N.K. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 134 (2007) 932-938
15. Kulik A., Brookhart M.A., Levin R., Ruel M., Solomon D.H., and Choudhry N.K. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 118 (2008) 1785-1792
16. Kokotailo R.A., and Hill M.D. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 36 (2005) 1776-1781
17. Adler G.S. A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev 15 (1994) 153-163
18. Solomon D.H., Schneeweiss S., Glynn R.J., Kiyota Y., Levin R., Mogun H., and Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109 (2004) 2068-2073
19. Brookhart M.A., Patrick A.R., Dormuth C., Avorn J., Shrank W., Cadarette S.M., and Solomon D.H. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 166 (2007) 348-354
20. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Kirby A., Sourjina T., Peto R., Collins R., and Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
21. Amar D., Zhang H., Heerdt P.M., Park B., Fleisher M., and Thaler H.T. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128 (2005) 3421-3427
22. Marin F., Pascual D.A., Roldan V., Arribas J.M., Ahumada M., Tornel P.L., Oliver C., Gomez-Plana J., Lip G.Y., and Valdes M. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 97 (2006) 55-60
23. Liakopoulos O.J., Choi Y.H., Haldenwang P.L., Strauch J., Wittwer T., Dorge H., Stamm C., Wassmer G., and Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 29 (2008) 1548-1559
24. Miceli A., Fino C., Fiorani B., Yeatman M., Narayan P., Angelini G.D., and Caputo M. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 87 (2009) 1853-1858
25. Patel A.A., White C.M., Shah S.A., Dale K.M., Kluger J., and Coleman C.I. The relationship between statin use and atrial fibrillation. Curr Med Res Opin 23 (2007) 1177-1185
26. Smith Jr. S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., Mosca L., Pasternak R.C., Pearson T., Pfeffer M.A., and Taubert K.A. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
27. Stewart S., Murphy N.F., Walker A., McGuire A., and McMurray J.J. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 90 (2004) 286-292